---
title: Abalos
date: 2019-10-15T07:44:19Z
modified: 2026-08-13T11:32:11Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/abalos/"
type: portfolio
status: publish
excerpt: ""
wpid: 75441
language:
  - English
post_translations:
  - pll_5da578c9b9883
branchen22:
  - Oncology
sectors:
  - Pharmaceuticals
focus_areas:
  - Oncology
timestamp: 2026-08-13T11:32:11Z
tags:
  - English
  - pll_5da578c9b9883
  - Oncology
  - Pharmaceuticals
---

## Beschreibungstext

Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise innate and adaptive immune responses and activate all relevant immune cell types against primary tumors and metastases. Led by experienced biotech entrepreneurs and immunology pioneers, Abalos’ goal is to achieve a quantum leap in immuno-oncology.

## Unternehmenswebsite

www.abalos-tx.com

## Adresse

Alfredstraße 81
45130 Essen
Germany

## Kontakt

Array